Display Settings:

Format

Send to:

Choose Destination
    Expert Opin Pharmacother. 2007 Jul;8(10):1433-9.

    The genetics of hereditary spastic paraplegia and implications for drug therapy.

    Source

    University of Miami Miller School of Medicine, Miami Institute of Human Genomics, Miami, FL 33101, USA. szuchner@med.miami.edu

    Abstract

    Hereditary spastic paraplegia (HSP) comprises a group of clinically and genetically heterogeneous diseases that affect the upper motor neurons and their axonal projections. A total of 30 chromosomal loci have been identified for autosomal dominant, recessive and X-linked HSP. The underlying genes for 15 of these loci have been described. The molecular dissection of the cellular functions of the related gene products has already greatly advanced our understanding of the most critical pathways involved in HSP. It is hoped that in the foreseeable future this knowledge will begin to translate into novel pharmacological approaches for this devastating disease.

    PMID:
    17661726
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Informa Healthcare

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk